Stock Split Signals: Two Major Companies Flashing Green Light in 2026

Understanding Why Stock Splits Matter

When a company’s share price climbs into four-figure territory, the board often considers implementing a stock split. While these corporate actions don’t fundamentally alter a company’s value, they serve an important strategic purpose—making shares more accessible to a broader investor base. As prices rise, retail investors naturally gain more interest in companies experiencing strong momentum. Stock splits historically coincide with periods of bullish market sentiment, creating a compelling reason to monitor which high-flyers might announce one soon.

Eli Lilly’s Path Toward a Split

The pharmaceutical giant has witnessed remarkable valuation expansion, with its share price now exceeding $1,000 following a dominant position in the rapidly growing weight-loss medication market. Eli Lilly’s incretin analog lineup, particularly Zepbound, has captured nearly 58% of the U.S. market share in this category—a testament to the company’s competitive advantage.

The numbers tell a compelling story: with a market capitalization surpassing $1 trillion and a forward price-to-earnings multiple around 27, the company projects earnings growth exceeding 35% for the upcoming year. The last stock split occurred in 1997—nearly three decades ago—suggesting the timing could align with current market conditions. Higher share prices typically prompt management to consider splits, especially when institutional and retail investor demand remains strong.

ASML: The Semiconductor Play Ready for a Reset

Netherlands-based ASML Holding manufactures advanced semiconductor equipment systems critical to chip production globally. Over the past year, shares have climbed more than 54%, reaching prices surpassing $1,100 per share. This trajectory mirrors that of other AI-adjacent winners benefiting from infrastructure investment.

Notably, ASML hasn’t executed a stock split for nearly 20 years. Current leadership guidance projects 2026 growth matching 2025’s strength, while sell-side analysts forecast 14.8% sales growth and 28.3% earnings expansion. These fundamentals suggest the company remains positioned for continued appreciation, which could ultimately trigger a split announcement.

The Investor Takeaway

For equity investors, monitoring stocks trading above $1,000 per share can reveal opportunities. Companies at this price level frequently announce splits to improve share accessibility, often coinciding with positive business momentum. Both ASML and Eli Lilly exhibit the hallmarks of split candidates—strong operational performance, significant recent gains, and extended periods since their last splits. Whether pursuing fractional shares or waiting for a formal split, keeping tabs on these names remains strategically sound in 2026.